Family

Loading Family data...

• 15 United States
• 10 France
• 8 Japan
• 7 China
• 5 Korea
• 2 Other

Patent Owner(s)

Patent Owner	Address
MAGNA STEYR FUEL SYSTEMS GESMBH	8261 SINABELKIRCHEN

International Classification(s)

• B29C:SHAPING OR JOINING OF PLASTICS; SHAPING OF SUBSTAN....
• B29L:INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RE....

• 2014 Application Filing Year
• B29C Class
• 4829 Applications Filed
• 3911 Patents Issued To-Date
• 80.99 % Issued To-Date

Inventor(s)

Inventor Name	Address	# of filed Patents	Total Citations
Drebes, Mario	Berlin, DE	6	17
# of filed Patents : 6 Total Citations : 17
Gross, Jörg	Wessling, DE	3	20
# of filed Patents : 3 Total Citations : 20

Cited Art Landscape

Load Citation

• No Cited Art to Display

Loading Cited Art Landscape...

Patent Citation Ranking

• 14 Citation Count
• B29C Class

• 92.11 % this patent is cited more than
• 9 Age

Forward Cite Landscape

Load Citation

• No Forward Cites to Display

Loading Forward Cite Landscape...

Maintenance Fees

Fee	Large entity fee	small entity fee	micro entity fee	due date
11.5 Year Payment	$7400.00	$3700.00	$1850.00	Feb 23, 2028

Fee	Large entity fee	small entity fee	micro entity fee
Surcharge - 11.5 year - Late payment within 6 months	$160.00	$80.00	$40.00
Surcharge after expiration - Late payment is unavoidable	$700.00	$350.00	$175.00
Surcharge after expiration - Late payment is unintentional	$1,640.00	$820.00	$410.00

DATE PUBLISHED	PUBLICATION/PATENT NO.	PUBLICATION TYPE
August 23, 2016	US,9421710,B2   US9421710B2	GRANTED PATENT AS SECOND PUBLICATION
October 09, 2014	US,20140300022,A1   US20140300022A1	FIRST PUBLISHED PATENT APPLICATION

Full Text

US Patent No: 8859522

Processes for the preparation of regadenoson and a new crystalline form thereof

---

Abstract

---

This disclosure relates to an improved process for the preparation of regadenoson, pharmaceutically acceptable salts thereof, and hydrates thereof, and for the preparation of intermediates useful in the synthesis of regadenoson. The disclosure also relates to a new crystalline form of regadenoson. Processes for the preparation of the crystalline form, compositions containing the crystalline form, and methods of use thereof are also described.

---

 

---

Description

---

Claims

---

Claims data not available

---

Legal Events

 

• MAFP2022
• AS2020
• AS2020
• MAFP2018
• FEPP2018
• AS�2017
• AS2017
• AS2017
• AS�2016
• AS2016
• AS2016
• I2014
• STCF2014
• P2014
• AS2013
• F2012
• PD2011

Date	Code	Event	Description
Mar 30, 2022	MAFP	MAINTENANCE FEE PAYMENT	free format text: PAYMENT OF MAINTENANCE FEE, 8TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1552); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY year of fee payment: 8
Nov 06, 2020	AS	ASSIGNMENT	free format text: TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS;ASSIGNOR:THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A.;REEL/FRAME:054440/0877 Owner name: RELIABLE BIOPHARMACEUTICAL, LLC, MISSOURI Effective Date: Nov 06, 2020 free format text: TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS;ASSIGNOR:THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A.;REEL/FRAME:054440/0877 Owner name: AVANTOR PERFORMANCE MATERIALS, LLC, CALIFORNIA Effective Date: Nov 06, 2020 free format text: TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS;ASSIGNOR:THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A.;REEL/FRAME:054440/0877 Owner name: APPLIED SILICONE COMPANY LLC, CALIFORNIA Effective Date: Nov 06, 2020 free format text: TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS;ASSIGNOR:THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A.;REEL/FRAME:054440/0877 Owner name: NUSIL TECHNOLOGY LLC, PENNSYLVANIA Effective Date: Nov 06, 2020 free format text: TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS;ASSIGNOR:THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A.;REEL/FRAME:054440/0877 Owner name: THERAPAK, LLC, CALIFORNIA Effective Date: Nov 06, 2020
Nov 06, 2020	AS	ASSIGNMENT	free format text: SECURITY AGREEMENT (NOTES);ASSIGNORS:AVANTOR FLUID HANDLING, LLC;AVANTOR PERFORMANCE MATERIALS, LLC;NUSIL TECHNOLOGY LLC;AND OTHERS;REEL/FRAME:054343/0414 Owner name: THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., AS NOTES COLLATERAL AGENT, PENNSYLVANIA Effective Date: Nov 06, 2020
Apr 16, 2018	MAFP	MAINTENANCE FEE PAYMENT	free format text: PAYMENT OF MAINTENANCE FEE, 4TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1551) year of fee payment: 4
Jan 10, 2018	FEPP	FEE PAYMENT PROCEDURE	free format text: ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: BIG.)
Nov 21, 2017	AS�	SECURITY INTEREST	free format text: SECURITY AGREEMENT;ASSIGNORS:AVANTOR PERFORMANCE MATERIALS, LLC;NUSIL TECHNOLOGY LLC;APPLIED SILICONE COMPANY LLC;AND OTHERS;REEL/FRAME:044528/0960 Owner name: THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., A Effective Date: Nov 21, 2017
Nov 21, 2017	AS	ASSIGNMENT	free format text: SECURITY AGREEMENT;ASSIGNORS:AVANTOR PERFORMANCE MATERIALS, LLC;NUSIL TECHNOLOGY LLC;APPLIED SILICONE COMPANY LLC;AND OTHERS;REEL/FRAME:044811/0400 Owner name: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT, NEW Y Effective Date: Nov 21, 2017
Nov 21, 2017	AS	ASSIGNMENT	free format text: RELEASE (REEL 040913 / FRAME 0118);ASSIGNOR:CITIBANK, N.A.;REEL/FRAME:044511/0265 Owner name: RELIABLE BIOPHARMACEUTICAL, LLC, MISSOURI Effective Date: Nov 21, 2017
Dec 13, 2016	AS�	SECURITY INTEREST	free format text: SECURITY AGREEMENT;ASSIGNOR:RELIABLE BIOPHARMACEUTICAL, LLC;REEL/FRAME:040913/0118 Owner name: CITIBANK, N.A., AS COLLATERAL AGENT, NEW YORK Effective Date: Dec 13, 2016
Nov 02, 2016	AS	ASSIGNMENT	free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:RELIABLE BIOPHARMACEUTICAL CORPORATION;REEL/FRAME:040277/0548 Owner name: RELIABLE BIOPHARMACEUTICAL, LLC, PENNSYLVANIA Effective Date: Nov 02, 2016
Oct 27, 2016	AS	ASSIGNMENT	free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:RELIABLE BIOPHARMACEUTICAL CORPORATION;REEL/FRAME:040174/0564 Owner name: RELIABLE BIOPHARMACEUTICAL, LLC, MISSOURI Effective Date: Oct 27, 2016
Oct 14, 2014	I	Issuance
Sep 24, 2014	STCF	INFORMATION ON STATUS: PATENT GRANT	free format text: PATENTED CASE
Feb 13, 2014	P	Published
Nov 01, 2013	AS	ASSIGNMENT	free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:WOOLDRIDGE, LUZVIMINDA T;MA, CHUN;NADJI, SOURENA;SIGNING DATES FROM 20131023 TO 20131026;REEL/FRAME:031530/0463 Owner name: RELIABLE BIOPHARMACEUTICAL CORPORATION, MISSOURI
Apr 26, 2012	F	Filing
Apr 27, 2011	PD	Priority Date